Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Megestrol Acetate antibody

The Sheep Polyclonal anti-Megestrol Acetate antibody has been validated for EIA. It is suitable to detect Megestrol Acetate in samples from Hormone.
Catalog No. ABIN487734

Quick Overview for Megestrol Acetate antibody (ABIN487734)

Target

Megestrol Acetate

Reactivity

  • 1
  • 1
Hormone

Host

  • 2
Sheep

Clonality

  • 2
Polyclonal

Conjugate

  • 2
This Megestrol Acetate antibody is un-conjugated

Application

  • 2
  • 1
  • 1
Enzyme Immunoassay (EIA)
  • Purification

    Ig Fraction

    Immunogen

    Megestrol acetate (3)-BTG

    Isotype

    IgG
  • Application Notes

    ELISA: 2.5 μg/mL.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    8.16mg/mL (U.V.abs at 280nm)

    Buffer

    20 mM Phosphate, 150 mM Sodium Chloride, pH 7.2 containing 0.09 % Sodium Azide as preservative

    Preservative

    Sodium azide

    Precaution of Use

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    Avoid repeated freezing and thawing.

    Storage

    -20 °C
  • Target

    Megestrol Acetate

    Target Type

    Hormone

    Background

    Megesterol: a synthetic progestational compound used to treat endometrial carcinoma and an appetite stimulant approved for the treatment of weight loss in people with AIDS. Megestrol acetate is a synthetic version of the female hormone PROGESTERONE. Most of the weight gain it leads to has been found to be fat rather than PROTEIN. Possible SIDE EFFECTS include HYPERGLYCEMIA, occasional impotence and decreased LIBIDO in men and uterine bleeding in women. Megestrol acetate is a synthetic progestogen used in the palliative management of recurrent, inoperable or metastatic endometrial carcinoma.
You are here:
Chat with us!